Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil for Pain Management in THA/TKA
NCT05307341Phase 4Unknown
- Sponsor
- MORE Foundation
- Start
- Mar 2022
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of sufentanil in postoperative pain, sponsored by MORE Foundation. Status: unknown.
02
Drugs
sufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05307341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05307341.